Encore Medical, Inc.
EMI
CIK:
0001838003
Company Information
Industry
Surgical & Medical Instruments & Apparatus
SIC Code
3841
Entity Type
other
State of Incorporation
MN
Business Address
2975 LONE OAK DRIVE, EAGAN, MN, 55121
Mailing Address
2975 LONE OAK DRIVE, EAGAN, MN, 55121
Phone
651-797-0913
Fiscal Year End
1231
EIN
822906303
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | April 6, 2026 | View on SEC |
| S-1/A IPO registration amendment | March 24, 2026 | View on SEC |
| S-1/A IPO registration amendment | March 3, 2026 | View on SEC |
| S-1/A IPO registration amendment | December 30, 2025 | View on SEC |
| S-1 IPO registration statement | September 15, 2025 | View on SEC |
IPO Filings
S-1
September 15, 2025
- Potential access to a $1.5 billion U.S. market for PFO closure devices targeting 139,000 annual stroke patients and 13 million migraine sufferers with PFO.
- Proven track record with 20+ years of global use, 35,000 patients treated internationally, and low complication rates.
Related Companies
Companies in the same industry (SIC: 3841)
RetinalGenix Technologies Inc.
RTGN
Surgical & Medical Instruments & Apparatus
Harvard Apparatus Regenerative Technology, Inc.
HRGN
Surgical & Medical Instruments & Apparatus
Nu-Med Plus, Inc.
NUMD
Surgical & Medical Instruments & Apparatus
Vivos Therapeutics, Inc.
VVOS
Surgical & Medical Instruments & Apparatus
Beyond Air, Inc.
XAIR
Surgical & Medical Instruments & Apparatus
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.